Endothelial dysfunction by flow-mediated dilation assessed ultrasonically in patients with Kawasaki Disease

Harumi Koibuchi1, Kazuhiko Kotani, Takaomi Minami

  • 1Department of Clinical Laboratory Medicine, Jichi Medical University, Shimotsuke-City, Japan - Kazukotani@jichi.ac.jp.

Minerva Pediatrica
|November 21, 2014
PubMed

Insights

Kawasaki Disease (KD) may cause endothelial dysfunction, indicated by lower flow-mediated dilation (FMD) in children. However, more research is needed to confirm this link and its clinical utility for vascular complications.

Area of Science:

  • Pediatric Cardiology
  • Vascular Biology
  • Rheumatology

Background:

  • Kawasaki Disease (KD) is a critical pediatric illness.
  • Coronary aneurysms are a severe complication of KD.
  • Endothelial dysfunction is implicated in KD's vascular pathology.

Purpose of the Study:

  • To systematically review studies on endothelial function in KD patients.
  • To evaluate endothelial dysfunction using flow-mediated dilation (FMD).
  • To assess the utility of FMD in managing KD vascular complications.

Main Methods:

  • Systematic review of PubMed-published clinical studies up to 2013.
  • Ultrasonic assessment of flow-mediated dilation (FMD) to measure endothelial function.
  • Comparison of FMD levels between KD patients and control groups.

Main Results:

  • Six of eight reviewed studies reported significantly lower FMD in KD patients.
  • Two studies found no significant difference in FMD between KD patients and controls.
  • Evidence suggests potential endothelial dysfunction in KD, but findings are inconsistent.

Conclusions:

  • Patients with Kawasaki Disease may exhibit endothelial dysfunction.
  • Current evidence is limited by small study sizes and lack of prospective vascular outcome data.
  • Further research is required to definitively establish FMD's role in KD and its vascular complications.

Related Concept Videos